Differences in clinical presentation and outcome between unstable angina and non-Q-wave infarction;Diferencias en la presentación clínica y el pronóstico de la angina inestable y el infarto sin onda Q

Revista Espanola de Cardiologia

Volumn 52, Issue SUPPL. 1, 1999, Pages 55-60

  Sambola, Antonia ^a   Sanz, Ginés ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Non Q wave myocardial infarction; Outcome; Prognosis; Unstable angina

Indexed keywords

FIBRINOLYTIC AGENT;

DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; HEART INFARCTION; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; TREATMENT OUTCOME;

EID: 0032603714     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-250, 310-318.
2. Willerson JT, Golino P, Eidt J, Campbell WB, Buja M. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation 1989; 80: 198-205.
3. Ambrose J. Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different? J Am Coll Cardiol 1992; 19: 1.653-1.658.
4. Falk E, Prediman KS, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671.
5. Fuster V, Lewis A. Conner memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2.126-2.146.
6. The RISC group. Risk of myocardial infarction and death during treatment wilh low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-830.
7. Cohen M, Xiong J, Parry G, Adams Ph, Chamberlain D, Wieczorek I et al. Prospective comparison of unstable angina versus nonQ wave myocardial infarction during antithrombotic therapy. J Am Coll Cardiol 1993; 22: 1.338-1.343.
8. Cohen M, Adams Ph, Parry G, Xiong J, Chamberlain D, Wieczorek I et al. Combination antithrombotic therapy in unstable rest angina and non-Q wave infarction in nonprior aspirin users. ATACS. Circulation 1994; 89: 81-88.
9. The TIMI IIIA Investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit lesion in patients presenting with ischemie cardiac pain at rest: results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 1993; 87: 38-52.
10. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994; 89: 1.545-1.556.
11. The FRISC Study Group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996; 347: 561-568.
12. Granger CB, Hirsch J, Califf RM, Col, J, White HD, Betriu A et al. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results of the from the GUSTO-I trial. Circulation 1996; 93: 870-878.
13. Marrugat J, Sanz G, Masid R, Valle V, Molina LI, Cardona M et al. Impact of accesibility to cardiac catheterization and coronary revascularization after myocardial infarction on 6-month outcome. J Am Coll Cardiol 1997; 30: 1.187-1.193.
14. Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie GG et al, for the FRIC Investigators. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Circulation 1997; 96: 61-68.
15. Cohen M, Demers C, Gurfinkel EP, Turpie AGO, Fromell GJ, Goodman S et al, for the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave coronary events study group. Low molecular weight heparin versus unfractionated heparin for unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1997; 337: 447-452.
16. Califf R, Mark D. Unstable angina: clinical presentation and diagnostic techniques. En: Fuster V, Ross R, Topol EJ, editores. Atherosclerosis and coronary artery diseases. Filadelfia: Lippincott-Raven, 1996: 1.299-1.314.
17. Burke AP, Farb A, Malcolm GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1.276-1.281.
18. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM et al. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of «preinfarction» angina. N Engl J Med 1978; 299: 1.271-1.277.
19. Hussain KM, Could L, Bhratan T, Angirekula M, Choubey S, Karpov Y. Arteriographic morphology and intracoronary thrombus in patients with unstable angina, non-Q wave myocardial infarction and stable angin apectoris. Angiology 1995; 46: 181-189.
20. Fuster V, Badimon L, Cohen M, Ambrose J, Badimon JJ, Chesebro JH. Insights into the pathogensis of acute ischemie syndromes. Circulation 1988; 77: 1.213-1.220.
21. Mizuno K, Satumora K, Miyamoto A, Arakawa E, Shibuya T, Arai T et al. Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes. N Engl J Med 1992; 326: 287-291.
22. Gold HK, Yasuda T, Jang IK, Guerrero JL, Fallon JT, Leinbach RC et al. Animal models for arterial thrombolysis and prevention of reocclusion- erythrocite-rich versus platelet-rich thrombus. Circulation 1991; 83 (Supl 4): 26-40.
23. Théroux P, Fuster V. Integrated pathogenesis of the various coronary syndromes and of unstable angina. Acute coronary syndromes. Unstable angina and non-Q-wave myocardial infarction. Circulation 1998; 97: 1.195-1.206.
24. Bogaty P, Hackett D, Davies G, Maseri A. Vasocreactivity of the culprit lesion in unstable angina. Circulation 1994; 90: 5-11.
25. Ahmed W, Bittl JA, Braunwald E. Relation between clinical presentation and angiographie morphology in unstable angina pectoris. Am J Cardiol 1988; 62: 1.024-1.027.
26. Cannon Ch, Thompson B, McCabe C, Mueller H, Kirshenbaum J, Herson S et al. Predictors of non-Q wave acute myocardial infarction in patients with acute ischemie syndromes: an analysis from ischemie syndromes: an analysis from the thrombolysis in myocardial ischemia (TIMI) III trials. Am J Cardiol 1995; 75: 977-981
27. Armstrong PW, Chiong MA, Parker JO. The spectrum of unstable angina: prognostic role of serum creatine kinase determination. Am J Cardiol 1982; 49: 1.849-1.852.
28. Boden WE, Baugh EW, Benham I, Shulman RS. Unstable angina with episodic ST elevation and minimal creatin Kinase release culminating in extensive, recurrent infarction. J Am Coll Cardiol 1983; 2: 11-20.
29. Hamm Ch, Goldmann B, Heeschen Ch, Kreymann G, Berger J, Meinertz Th. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1.648-1.653.
30. Lüscher M, Thygesen K, Ravkilde J, Heickendorff, for the TRIM study group. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997; 96: 2.578-2.585.
31. Liuzzo G, Biasucci LM, Gallimore JR, Gallimore JR, Grillo R, Rebuzzi A et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
32. Grambow DW, Topol EJ. Effect of maximal medical therapy on refractoriness of unstable angina pectoris. Am J Cardiol 1992; 70: 577-581.
33. Caims JA, Singer J, Gent M, Finnie KJ, Froggatt GM, Holder DA et al. One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375.000 people. Can J Cardiol 1989; 5: 239-246.
34. Mulcahy R, Al Awadhi AM, De Buitleor M, Tobin G, Johnson H, Contoy R. Natural history and prognosis of unstable angina. Am Heart J 1985; 109: 753-758.
35. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE III et al. Protective effects of aspirin aginst acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med 1983; 309: 396-403.
36. Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt JM, Holder DA et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N Engl J Med 1985; 313: 1.369-1.375.
37. Lee HS, Cross SJ, Rawles JM, Jennings KP. Patients with suspected myocardial infarction who present with ST depression. Lancet 1993; 342: 1.204-1.207.
38. Liebson Ph, Klein LI. The non-Q wave myocardial infarction revisited: 10 years later. Progr Cardiovasc Dis 1997; 39: 399-444.
39. Gibson RS. Non-Q-wave myocardial infarction. En: Fuster V, Ross R, Topol EJ, editores. Atherosclerosis and coronary artery diseases. Filadelfia: Lippincott Raven, 1996; 1.097-1.123.
40. Stone Ph, Raabe Ds, Jaffe AS, for the MILIS Group. Pronostic significance of location and type of myocardial infarction; independent adverse outcome associated with anterior location. J Am Coll Cardiol 1988; 11: 453-463.
41. Gibson R, Boden W, Théroux P, Strauss HD, Prall CM, Gheorgiade M et al. Diltiazem and reinfarclion in palienls wilh non-Q-wave myocardial infarclion. N Engl J Med 1986; 315; 423-429.
42. Guidelines for coronary angiography: a report of the American College of Cardiology/American heart Association Task Force on Assessmenl of diagnostic and therapeulic cardiovascular procedures (subcommittee on coronary angiofgrphy). J Am Coll Cardiol 1987; 10: 935-950.
43. Pepine CJ, Allen HD, Bashore TM, Brinker J, Cohn L, Dillon J et al. American College of Cardiology/American Heart Association guidelines for cardiac cathelerizalion and cardiac calhelerizalion laboralories. J Am Coll Cardiol 1991; 18: 1.149-1.182.
44. Ryan TJ, Anderson JL, Amman EM, Antman E, Braniff B, Brooks N et al. ACC/AHA guidelines for the managemenl of palienls with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Commitlee on managemenl of acute myocardial infarction). J Am Coll Cardiol 1996; 28: 1.328-1.428.
45. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ el al. A randomizaed trial of immediale versus delayed elective angiography after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987; 317: 581-588.
46. The TIMI research group. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarclion. TIMI HA results. JAMA 1988; 260: 2.849-2.858.
47. Rouleau JL, Moyé LA, Pfeffer MA, Arnold M, Bernstein V, Luddy Th et al. A comparison of management patterns after acute myocardial infarction in Canada and the United Stales. N Engl J Med 1993; 328: 779-784.